At a glance
ClinicalIndex Comparison RecordN/ACompleted· 49 enrolled
Drug / intervention
Enhanced Usual Care (EOC) +1 morebehavioral
Likely dose
REVITALIZE ACT intervention: six 60-75 minute telehealth sessions approximately once a week for 6-8 weeksAI-extracted
Key inclusion· 6
- ✓Women ≥18 years of age
- ✓Diagnosed with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
- ✓Receiving PARP inhibitors for ≥2 months
- ✓ECOG performance status 0-2
Key exclusion· 6
- ✕Untreated clinical conditions or comorbidities (e.g., anemia, hypothyroidism) that could explain fatigue
- ✕Chronic severe fatigue predating PARP inhibitor use
- ✕Pregnant women
- ✕Prisoners
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue
In Brief
A clinical study evaluating Enhanced Usual Care (EOC) and REVITALIZE ACT Intervention for Ovarian Cancer and 3 related conditions. Completed, enrolled 49 participants across 2 sites.
Detailed Summary
This study is testing whether a 6 week skills-based telehealth intervention can help ovarian cancer patients experiencing PARP inhibitor-related fatigue reduce the impact of fatigue on their daily life and activities.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Cancer, Fatigue, Coping Behavior, Coping Skills
CountriesUnited States
CollaboratorsAstraZeneca, National Comprehensive Cancer Network
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartDec 2020
Primary CompletionAug 2022
TodayJul 2026
First PostedAug 25, 2020
Enrollment StartDec 2, 2020
Primary CompletionAug 9, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.9 years ago
Interventions
Enhanced Usual Care (EOC)behavioral
Educational materials
REVITALIZE ACT Interventionbehavioral
Six 60-75 minute telehealth sessions approximately once a week for 6-8 weeks